Early treatment-related changes in dorsolateral prefrontal cortex activity and functional connectivity as potential biomarkers for antidepressant response in major depressive disorder
Open Access
- 6 October 2025
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-9
Abstract
Cognitive deficits are prevalent in major depressive disorder (MDD). Given that the dorsolateral prefrontal cortex (DLPFC) is a crucial region within the executive control network, its activity and functional connectivity (FC) may serve as potential indicators of antidepressant response. This prospective cohort study recruited 115 MDD patients and 43 healthy controls. Psychological assessments, electroencephalogram and event-related potential recordings were performed at baseline and 1 week after venlafaxine treatment, with a 12-week follow-up. Independent sample t-tests and Mann-Whitney U tests analyzed group differences, while linear mixed-effects models and logistic regression evaluated associations between DLPFC activity/FC changes and clinical outcomes. The MDD group showed significantly reduced right DLPFC current density during the N2 time window evoked by oddball stimuli (p = 0.028). Higher right DLPFC current density during the N2 time window was correlated with lower HAMD-21 scores one week after treatment (p = 0.041, n = 46). Furthermore, an early increase predicted remission at week 12 (p = 0.005). Decreased beta-band FC between the left DLPFC and both side of posterior cingulate cortex (PCC) (left: p = 0.003; right: p = 0.004) were correlated with lower HAMD-21 scores (n = 71). Moreover, an early reduction in these connectivity measures (left: odds ratio (OR) = 0.534, 95% confidence interval (CI): 0.297–0.972, p = 0.036; right: OR = 0.533, 95% CI: 0.299–0.950, p = 0.033) predicted remission at week 12. Early changes in DLPFC activity and FC may serve as biomarkers for monitoring treatment efficacy and predicting clinical outcomes, informing personalized treatment approaches.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (82090034, 82090034)
This publication has 46 references indexed in Scilit:
- A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depressionInternational Journal of Neuropsychopharmacology, 2008
- Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled TrialBiological Psychiatry, 2007
- Phase lag index: Assessment of functional connectivity from multi channel EEG and MEG with diminished bias from common sourcesHuman Brain Mapping, 2007
- Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical PracticeAmerican Journal of Psychiatry, 2006
- The P300: Where in the Brain Is It Produced and What Does It Tell Us?The Neuroscientist, 2005
- Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depressionThe British Journal of Psychiatry, 2002
- Event-related potentials (ERPs) to hemifield presentations of emotional stimuli: differences between depressed patients and healthy adults in P3 amplitude and asymmetryInternational Journal of Psychophysiology, 2000
- The visual N1 component as an index of a discrimination process.2000
- Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophreniaPsychiatry Research: Neuroimaging, 1999
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960